Source,TTY

 1  HHC96DX|      information on tests to identify disease or assess health condition.~
 2  HHC96DX|          intake.~Knowledge Deficit of Disease Process [C0184527] [D08.
 3  HHC96DX|          regulated course of treating disease.~Meaningfulness Alteration [
 4  HHC96DX|  recommendations on tests to identify disease or assess health condition.~
 5  HHC96DX|          regulated course of treating disease.~Nutrition Alteration [C0184548] [
 6  NAN94PT|             and signs and symptoms of disease, if present, are controlled.]~
 7  NIC93RT|             NOCODE]~----~communicable disease prevention [C0150522] [NOCODE]~----~
 8  NIC93RT|               C0150549] [NOCODE]~----~disease prevention [C0150550] [NOCODE]~----~
 9  NIC96AC|              for sexually transmitted disease, if culture positive [C0508383] [
10  NIC96AC|              for sexually transmitted disease if partner exhibits any
11  NIC96AC|         knowledge related to specific disease process [C0508580] [U000501]~----~
12  NIC96AC|        patient's understanding of the disease process [C0508586] [U000507]~----~
13  NIC96AC|               family history of heart disease and dysrhythmias [C0508626] [
14  NIC96AC|         congenital condition, injury, disease, or surgery [C0509018] [
15  NIC96AC|              focusing on diagnosis or disease process alone when assisting
16  NIC96AC|             signs and symptoms of the disease, as appropriate [C0509844] [
17  NIC96AC|            U001792]~----~Describe the disease process, as appropriate [
18  NIC96AC|      complications and/or control the disease process [C0510293] [U002232]~----~
19  NIC96AC|               to prevent thrombolytic disease [C0510842] [U002790]~----~
20  NIC96AC|            the pathophysiology of the disease and how it relates to the
21  NIC96AC|       chemical dependency is a family disease [C0511532] [U003491]~----~
22  NIC96AC|           eating experiences, injury, disease, culture, and finances in
23  NIC96AC|             fever, another infectious disease, or skin lesions at site
24  NIC96AC|          minimize side effects of the disease, as appropriate [C0512517] [
25  NIC96AC|               exposed to communicable disease [C0512631] [U004600]~----~
26  NIC96AC|              depression, neurological disease, chronic lung disease, musculoskeletal
27  NIC96AC|    neurological disease, chronic lung disease, musculoskeletal disease,
28  NIC96AC|              disease, musculoskeletal disease, chest trauma, infection,
29  NIC96AC|        Monitor for underlying medical disease that can lead to electrolyte
30  NIC96AC|           medication against venereal disease [C0514104] [U006137]~----~
31  NIC96AC|              for sexually transmitted disease or vaginal infection [C0514482] [
32  NIC96AC|         positive sexually transmitted disease cultures, as required by
33  NIC96AC|             visitors for communicable disease [C0515686] [U007759]~----~
34  NIC96AC|    tuberculosis, sexually transmitted disease, hemoglobinopathies, Tay-Sachs,
35  NIC96AC|          disorder, such as Huntington disease [C0515943] [U008020]~----~
36  NIC96AC|         National Health Promotion and Disease Prevention Objectives or
37  NIC96AC|                    Teach pathology of disease to sibling, according to
38  NIC96PT|            prevention of communicable disease~Impulse Control Training [
39  NIC96PT|                             Teaching: Disease Process [C0150374] [5602]~
40  NIC96PT|     information related to a specific disease process~Teaching: Group [
41  NIC96SA|              from side effects of the disease and treatment [C0516500] [
42  NOC97HC|        subjective states triggered by disease or illness~Tissue Integrity [
43  NOC97ID|             080113]~----~Acknowledges disease risk without immunization [
44  NOC97ID|           180810]~----~Description of disease process [C0517726] [180302]~----~
45  NOC97ID|             Description of effects of disease [C0517729] [180305]~----~
46  NOC97ID|               of measures to minimize disease progression [C0517732] [
47  NOC97ID|            transmission of infectious disease [C0517764] [180514]~----~
48  NOC97ID|                  Description of usual disease course [C0517731] [180307]~----~
49  NOC97ID|         230009]~----~Familiarity with disease name [C0517725] [180301]~----~
50  NOC97ID|                 170505]~----~Focus on disease prevention and management [
51  NOC97ID|         Knowledge of care recipient's disease process [C0516912] [220205]~----~
52  NOC97ID|             220205]~----~Knowledge of disease process [C0516956] [220503]~----~
53  NOC97ID|                   Monitors changes in disease status [C0518787] [160911]~----~
54  NOC97ID|             190603]~----~Monitors for disease side effects [C0518786] [
55  NOC97ID|              problems associated with disease [C0518848] [120608]~----~
56  NOC97OC|              preventable communicable disease~Impulse Control [C0517616] [
57  NOC97OC|        conveyed about diet~Knowledge: Disease Process [C0517724] [1803]~
58  NOC97OC|             conveyed about a specific disease process~Knowledge: Energy
59  OMS94PR|      precautions against infection or disease, and promotion of health.~
60 PCDS97GO|             within constraints of the disease or surgical procedure. [
61 PCDS97GO|        perfusion to areas affected by disease or treatment as evidenced
62 PCDS97GO|        function within constraints of disease, surgery, etc. [C0548787] [
63 PCDS97OR|                  Assess perception of disease or injuries. [C0547386] [
64 PCDS97OR|               impairment from injury, disease or surgery. [C0548404] [
65 PCDS97OR|         ineffective coping related to disease process. [C0547484] [ORC_
66 PCDS97OR|           plan for patient with renal disease. [C0547788] [ORC_09900.01]~----~
67 PCDS97OR|           plan for patient with renal disease on medications related to
68 PCDS97OR|            related to end stage renal disease (ESRD). [C0547789] [ORC_
69 PCDS97OR|         chronic obstructive pulmonary disease (COPD). [C0548103] [ORC_
70 PCDS97OR|               with degenerative joint disease. [C0547193] [ORC_00870.00]~----~
71 PCDS97OR| cardiovascular or peripheral vascular disease. [C0547252] [ORC_02020.01]~----~